Published in Soc Sci Med on October 01, 2004
Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics. Drug Alcohol Rev (2005) 4.02
The gendered context of initiation to injecting drug use: evidence for women as active initiates. Drug Alcohol Rev (2007) 1.65
Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Clin Infect Dis (2005) 1.36
Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men. Sex Transm Infect (2012) 1.29
Single index of multimorbidity did not predict multiple outcomes. J Clin Epidemiol (2005) 1.25
The social production of hepatitis C risk among injecting drug users: a qualitative synthesis. Addiction (2008) 1.24
How can hepatitis C be prevented in the long term? Int J Drug Policy (2007) 1.18
Rural general practitioner apprehension about work related violence in australia. Aust J Rural Health (2003) 1.15
Prisons, hepatitis C and harm minimisation. Med J Aust (2007) 1.14
Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study. Clin Infect Dis (2013) 1.09
Putting at risk what we know: reflecting on the drug-using subject in harm reduction and its political implications. Soc Sci Med (2006) 1.05
Needle sharing in regular sexual relationships: an examination of serodiscordance, drug using practices, and the gendered character of injecting. Drug Alcohol Depend (2009) 1.00
Some characteristics of early-onset injection drug users prior to and at the time of their first injection. Addiction (2006) 0.99
Resilient coping: applying adaptive responses to prior adversity during treatment for hepatitis C infection. J Health Psychol (2008) 0.97
Perceptions of discriminatory treatment by staff as predictors of drug treatment completion: utility of a mixed methods approach. Drug Alcohol Rev (2010) 0.96
Equity of access to treatment, and barriers to treatment for illicit drug use in Australia. Addiction (2007) 0.94
HIV-negative and HIV-positive gay men's attitudes to medicines, HIV treatments and antiretroviral-based prevention. AIDS Behav (2013) 0.93
The experience of interferon-based treatments for hepatitis C infection. Qual Health Res (2005) 0.90
Indigenous Australian medical students' perceptions of their medical school training. Med Educ (2009) 0.89
Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales. Drug Alcohol Rev (2006) 0.89
Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney. Drug Alcohol Rev (2010) 0.88
Trauma, damage and pleasure: rethinking problematic drug use. Int J Drug Policy (2007) 0.88
Addiction journal is committed to publishing qualitative research. Addiction (2013) 0.87
Under the watchful eye of 'a benevolent dictator' - general practitioner and patient experiences of hepatitis C treatment initiation and shared-care in general practice. Aust Fam Physician (2013) 0.87
Initiators: an examination of young injecting drug users who initiate others to injecting. AIDS Behav (2007) 0.86
One size fits all? The discursive framing of cultural difference in health professional accounts of providing cancer care to Aboriginal people. Ethn Health (2013) 0.85
Producing the "problem" of addiction in drug treatment. Qual Health Res (2013) 0.84
Chronic illness experiences, clinical markers and living with hepatitis C. J Health Psychol (2007) 0.83
Willingness to use HIV pre-exposure prophylaxis has declined among australian gay and bisexual men: results from repeated national surveys, 2011-2013. J Acquir Immune Defic Syndr (2014) 0.83
Pleasure and drugs. Int J Drug Policy (2008) 0.82
Staying safe from hepatitis C: engaging with multiple priorities. Qual Health Res (2011) 0.82
At the intersection of marginalised identities: lesbian, gay, bisexual and transgender people's experiences of injecting drug use and hepatitis C seroconversion. Health Soc Care Community (2013) 0.81
Pretreatment preparation and management of interferon-based therapy for hepatitis C virus infection. J Adv Nurs (2007) 0.81
Evaluation of an integrated care service facility for people living with hepatitis C in New Zealand. Int J Integr Care (2012) 0.81
Harm minimisation in Australian prisons--health protection still depends on where you serve your time. Med J Aust (2012) 0.80
'Not just methadone Tracy': transformations in service-user identity following the introduction of hepatitis C treatment into Australian opiate substitution settings. Addiction (2014) 0.79
The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection. Int J Drug Policy (2007) 0.78
Improving surveillance for acute hepatitis C. Commun Dis Intell Q Rep (2011) 0.78
Public opinion on needle and syringe programmes: avoiding assumptions for policy and practice. Drug Alcohol Rev (2007) 0.78
Health worker attitudes toward peer workers in hepatitis C prevention. Psychol Health Med (2012) 0.78
The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics. Soc Sci Med (2011) 0.78
Discrimination by health care workers versus discrimination by others: countervailing forces on HCV treatment intentions. Psychol Health Med (2014) 0.78
Exploring the role of consumer participation in drug treatment. Drug Alcohol Depend (2009) 0.77
Depression, Anxiety, and Stress Among People With Chronic Hepatitis C Virus Infection and a History of Injecting Drug Use in New South Wales, Australia. J Addict Med (2016) 0.76
Preventing transitions to injecting amongst young people: what is the role of Needle and Syringe Programmes? Int J Drug Policy (2009) 0.76
Disclosing hepatitis C infection within everyday contexts: implications for accessing support and healthcare. J Health Psychol (2010) 0.76
Addiction and dependence: making realities in the DSM. Addiction (2011) 0.76
Young people at risk of transitioning to injecting drug use in Sydney, Australia: social disadvantage and other correlates of higher levels of exposure to injecting. Health Soc Care Community (2014) 0.76
The proof is in the toothpaste: police ordered exclusion as a result of research participation. Aust N Z J Public Health (2010) 0.75
NSPs and the media: a case study of balanced and accurate reporting? Aust N Z J Public Health (2005) 0.75
Assessing community support for harm reduction services: comparing two measures. Drug Alcohol Rev (2010) 0.75
Representations of people with HIV and hepatitis C in editorials of medical journals: discourses and interdiscursive relations. Commun Med (2006) 0.75
The place of volition in addiction: differing approaches and their implications for policy and service provision. Drug Alcohol Rev (2012) 0.75
'Makes you wanna do treatment': benefits of a hepatitis C specialist clinic to clients in Christchurch, New Zealand. Health Soc Care Community (2012) 0.75
"I Had a Little Bit of a Bloke Meltdown…But the Next Day, I Was Up": Understanding Cancer Experiences Among Aboriginal Men. Cancer Nurs (2016) 0.75
Applied communitarian ethics for harm reduction: promoting a dialogue within the field. Drug Alcohol Rev (2007) 0.75
'Towards a global approach'--an overview of Harm Reduction 2008: IHRA's 19th International Conference. Int J Drug Policy (2008) 0.75
Social inclusion and hepatitis C: exploring new possibilities for prevention. Expert Rev Anti Infect Ther (2011) 0.75
Knowledge and attitudes towards hepatitis C and injecting drug use among mental-health support workers of a community managed organisation. Aust Health Rev (2013) 0.75